Top Tweets for #sn111
Your AI agent read the paper.
Claims @DeSciClaims read the evidence.
#SN111 on $TAO turns “trust me, I summarized it” into claims, verbatim quotes and receipts.
Science deserves better than confident vibes.
Our new competition is live!
31 submissions are competing.
We'll run the winner in production next week. 🚀
AI can write a literature review. Asking it to show its work gets interesting.
Meet @DeSciClaims #SN111: turning papers into structured claims with verbatim evidence, checked by independent AI reviewers.
Miners compete on extraction quality. Research agents get receipts, not just prose.
Our new competition is live!
31 submissions are competing.
We'll run the winner in production next week. 🚀
Bittensor|| $TAO || #SN111
The new weekly competition by @DeSciClaims has already attracted 31 submissions. #SN111 is transitioning from producing approximately 10 extractions per paper to selecting and deploying a single best performing pipeline in production.
According to the team's cost projections, this approach could deliver 10–100 times more paper coverage per dollar of emissions. I'll be monitoring the weekly output and evaluating the consistency of agreement across the results.
Our new competition is live!
31 submissions are competing.
We'll run the winner in production next week. 🚀
Stuff like this is going to evolve the Bittensor landscape so fast.
This could apply to tons of miners.
I wonder if any @DeSciClaims #sn111 miners are using it? I feel there's huge potential 👀
“Claims provides the best evaluation for scientific records at a cost that scales”
Over at @ExploitSummit, Claims co-founder @nashgambit broke down the three key verification models for scientific records within #SN111, all live on mainnet.
Bronze: “Inexpensive compute to compare miner submissions with reference outputs.”
Silver: “Higher-quality compute used only when there is disagreement between the reference outputs and the miners.”
Gold: “Human-assisted adjudication, with a live consensus loop in v1 where miners assess the hard cases Silver can’t resolve automatically.”
All three are active now.
See the dashboard: https://t.co/WN79QNYdps
“Arguably the most important source of knowledge that we have as humans is buried in heaps of prose that machines cannot make sense of”
@PKoellinger explains at @ExploitSummit how science is a part of the internet that AI cannot process on its own.
#SN111 is designed to treat that issue, mapping information from papers into validated AI-friendly records that speed up research.
23 trials, 18,851 women, zero definitive papers.
That’s not a literature gap that’s an alpha gap.
@DeSciClaims #SN111 just turned maybe into a map:
Tamoxifen + ovarian suppression: 9.1% vs 11.7% 10‑yr breast‑cancer mortality (<45yo)
Pre‑tamoxifen era: 39.1% vs 56.5% 15‑yr recurrence
Cost: worse hot flushes, bone loss, almost no QoL data
AI doesn’t replace the registries. It tells you exactly which ones to query.
Decentralized claim evidence graphs > press release medicine.
23 clinical trials had tested whether switching off a woman's ovaries helps her survive #BreastCancer.
But not one could tell whether it adds anything on top of the drugs she is already taking.
These cancers are fed by oestrogen. Before menopause the ovaries are the main source, so they can be taken out with surgery, closed down with radiation, or switched off with drugs.
The drugs are chemotherapy and tamoxifen. Chemotherapy kills dividing cells. Tamoxifen stops the cancer from responding to oestrogen.
Earlier reviews had found no clear benefit from switching off the ovaries.
So the Early Breast Cancer Trialists' Collaborative Group went back for the individual records: what happened to each woman, rather than each trial's summary results.
18,851 women. That is 98.9% of every woman randomised in eligible trials of this treatment.
The oldest trial began enrolling in 1948, at the Christie Hospital in Manchester (@TheChristieNHS). It was the first cancer treatment ever assessed in a randomised trial. Its long-term survival data came from @NHS records.
The women were typically in their early forties when they joined, and were followed for more than a decade.
The result, among women who were under 45 when they joined and were already taking tamoxifen:
9.1% of those who also had their ovaries switched off had died of breast cancer within ten years. Among those on tamoxifen alone, 11.7% had.
In the older trials, where none of the women received tamoxifen, the gap was wider. Cancer came back within 15 years in 39.1% of the women whose ovaries were switched off, and in 56.5% of the women whose were not.
Switching off the ovaries has costs. The women whose ovaries were switched off had consistently more severe hot flushes than the women whose were not, and it is known to cause bone loss, which can be monitored and managed. Only 4 of the 23 trials measured quality of life at all.
Across the trials there was no increase in deaths from other causes, and none in second cancers.
This paper went through Claims this week:
8 adjudicated claims, each tied to its evidence.
This is the shape of question we want a claim-evidence graph to surface: 23 trials, one claim between them, and no single paper that settles it.
Getting the answer still needs the individual patient records, the original investigators and a national mortality register. The Claims database and AI do not produce that part.
But they can point to where someone should look.

Science wrote 300M papers for humans.
@DeSciClaims #SN111 on $TAO turns them into a machine readable claim evidence graph so AI can reason over what science actually shows.
Miners extract claims with evidence and provenance, validators selectively verify and calibrate and rewards follow distinct information families to limit Sybil gaming.
The result is a live, continuously learning market for trustworthy scientific data, not just another PDF graveyard.
Our v1 whitepaper has dropped.
Claims is live today in v0. This paper sets out what comes next: the architecture, verification model and incentive design behind the move to v1.
Read it here:
https://t.co/nqujLdjsWT

Great in depth interview by Grant!
Featuring @PKoellinger & @nashgambit of @DeSciClaims #SN111
If executed properly and adopted as the default infra for scientific knowledge, Claims could plausibly be valued in the $5–20 billion range as a standalone data/AI infra asset, with a high end global scientific OS scenario pushing toward $30–50 billion.
Building a position here could potentially retire your bloodline.
Ep. 99 - Philipp Koellinger & Christian Roessler
Philipp and Christian are building Claims @DeSciClaims Subnet 111
Timestamps
0:00 - Highlights
1:48 - Proof of Pitch to Mainnet in Three Months
2:50 - Why Economists Find Bittensor Fascinating
3:42 - Citations as Science's Reward Function
4:29 - The Replication Nobody Would Publish
6:53 - How Much Published Science Is Wrong
8:26 - The AI Echo Chamber vs. Human Work
9:54 - Making 300 Million Papers Machine Readable
15:11 - Reproducibility vs. Citations
15:46 - Turning Papers Into a Knowledge Graph
16:20 - Why LLMs Hallucinate Citations
21:21 - Longer Context Windows Make This Obsolete?
22:56 - Coverage, Extraction Quality & Evidence Quality
25:16 - What Counts as a Substantive Claim
26:42 - What This Is Worth to Working Academics
27:37 - Academia Admits the System Is Broken
29:26 - How Do You Actually Find the Truth?
32:06 - Truth as Probability, Not Zero or One
33:33 - Logical Proof vs. Physical Replication
35:44 - Correlation vs. Causality
36:28 - Ground Truth From Replication Studies
38:12 - Codifying Claims to Surface Contradictions
40:14 - Can You Trust an LLM as a Judge?
42:48 - Synthetic Checks: Truth Is Sparse
45:40 - How Much Miner Variance Is Desirable
46:55 - Why Bittensor Instead of a Closed Company
49:50 - Success, Revenue & the Palantir Comparison
51:47 - The Flood of AI-Written Papers
54:36 - Advice for Discerning Truth
@bitstarterAI season in coming 👌🏼
#SN87 @provenonce_ai
#SN91 @cascade_sn91
#SN111 @DeSciClaims
$TAO #DTAO
@bitstarterAI season in coming 👌🏼
#SN87 @provenonce_ai
#SN91 @cascade_sn91
#SN111 @DeSciClaims
$TAO #DTAO
TAO emissions to SN111 have been switch on, following our successful mainnet launch.
Congrats to the @DeSciClaims #SN111 team on mainnet launch. It was only a few months ago I watched you pitch on stage in Paris at @proofoftalk. The progress has been absolutely amazing!
Claims is live on mainnet.
Miners now compete to turn papers into structured claims and source evidence. Validators score the work. The best work earns the weight. Each round builds the canonical graph of science.
450 testnet papers led here. Day 0 starts now.⏱️
#SN111 👀
Thinking of registering multiple identities?
That won't help you unless you are a top performer.
Because you're always pitted against the best.
👉 Mainnet: Aug 28.
I don’t think it would be smart to sell all the alpha received from the pledges on subnets #SN111 & #SN87 and wait a few months :)
Just saying.. 👀
@DeSciClaims @provenonce_ai @bitstarterAI
#SN111 is what happens when real demand meets a properly designed incentive machine:
enterprise need ✅
paying demand ✅
live ahead of roadmap ✅
Instead of static datasets, they’ve built a system that learns how to judge itself in real time.
Falsified ground truth injection + miner consensus = continuous signal
refinement without human bottlenecks
This isn’t just data extraction it’s scalable truth discovery for scientific literature
bittensor:native keeps proving that open competition > closed pipelines
@DeSciClaims Mainnet in August is going to matter
The roadmap's out 🛣️
We didn't start with a mechanism hunting for a use. We started with a problem: an enterprise client needs a data-extraction pipeline they can't build themselves - and they're not the only ones asking. The demand is real, and it's willing to pay.
Big companies could build a version of this. Several are trying. But Bittensor offers continuous, open competition steered by an incentive mechanism built to reward data quality at scale. That's how you pull structured claims and evidence out of scientific literature at unprecedented volume and accuracy.
We're already live on testnet - 12 days ahead of our own roadmap. Mainnet follows end of August.
V0 launches deliberately simple: miners scored on extraction alone, tight scope, low volume, every interaction logged. Things will break, and they'll get fixed fast, in the open.
Then V1 adds the part that compounds. Miners also judge which of two extractions is better - and the validator quietly seeds some cases with falsified records it already knows the answer to. Miners can't tell which. Vote wrong on those and you're penalised; everywhere else, consensus pays. Ground truth gets injected continuously, so the system sharpens itself - no expensive human goldsets required.
To mine: a computer, access to an LLM, a wallet. That's it - testnet or mainnet. Starter code's on GitHub: https://t.co/PRpBEfmReA

Claims #SN111 is positioning itself at the center of one of the largest untapped markets in the world.
Scientific research is a trillion dollar industry that is still fragmented, slow and gate kept. Pharma spends over $200 billion per year on research and development
Global academic research funding exceeds 2 trillion annually.
Yet access to data, validation and reproducibility remains inefficient and siloed.
Commoditizing research changes everything.
When experiments, data, and validation become programmable and accessible through decentralized infrastructure, you unlock a global market of researchers, AI agents, biotech startups and institutions all competing and collaborating in real time
This is where Claims Cloud becomes critical
@DeSciClaims transforms research into verifiable, tradable and composable assets. It enables trustless validation of scientific outputs, turning knowledge into something that can be priced, exchanged and built upon without friction.
Instead of waiting months for peer review, results can be validated continuously.
Instead of closed silos, data becomes a shared economic layer.
Instead of wasted duplication, incentives align around truth and efficiency.
Subnet 111 is not just improving research workflows
It is turning science into an open market
Markets this large do not stay inefficient forever:
Follow the incentives
Follow the infrastructure
Follow the subnets that turn knowledge into capital

💥@DeSciClaims #SN111 is building the credibility layer for science.
Paper → extraction → anonymization → blind audit → control tests on validators → auditable database.
Adversarial by design. Trustable by construction.
A structured map of science is only useful if every record in it is trustworthy.
So we built the pipeline to be adversarial: miners extract, validators audit blind, and a control layer runs hidden tests on the validators themselves.
Here’s how a paper becomes an auditable record👇

The pattern is clear: every leap in science came from better ways to store, see or share truth.
@DeSciClaims #SN111 isn’t just another tool in that lineage... it’s the layer that makes knowledge legible to machines.
If AI is the engine, Claims is the fuel standard. Bullish on whoever owns the schema of truth.
New technologies have always enabled scientific progress.
Paper, the printing press, microscopes, telescopes, computers, networks, sequencers...
AI may be the biggest and most profound of them all. Claims builds the context database on which future research AI will run.
Science doesn’t need another chatbot. It needs a cap table for truth.
If @DeSciClaims #SN111 actually prices replication, contradictions and evidence weight instead of vibes, this could quietly become one of the most valuable datasets in AI.
https://t.co/amWoIVkMI8
Last Seen Hashtags on Sotwe
مبادل
Seen from Switzerland
روابط_iplayer
Seen from Egypt
curvi
Seen from Spain
galvino
Seen from United States
snapchatt
Seen from United States
千葉東
Seen from Japan
selfie
Seen from Turkey
cousin()((((((((**********************************************)))))))) +filter:videos
Seen from United States
viralawekmalaysia
Seen from Malaysia
jungkooktop
Seen from Austria
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.4M followers

Barack Obama 
@barackobama
118.7M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.7M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
83.9M followers

Lady Gaga 
@ladygaga
75.4M followers

Virat Kohli 
@imvkohli
73.3M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.3M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.1M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers






